The firm raised the money last week in a public offering of 14,375,000 common shares, and it will use the money for working capital and general corporate purposes.

NEW YORK – Cancer Research Horizons, a translational subsidiary of Cancer Research UK, announced on Monday that it has awarded £230,000 ($302,582) to researchers at the University of Birmingham to ...

NEW YORK – Cancer Research Horizons, a translational subsidiary of Cancer Research UK, announced Monday that it has awarded £230,000 ($302,582) to researchers at the University of Birmingham to ...

The all-stock deal combines Longevity's human longevity and health aging products with 20/20s lab tests including its OneTest multi-cancer early detection assay.

NEW YORK – Federal prosecutors said on Wednesday that a North Carolina woman has pleaded guilty to fraudulently billing the state's Medicaid program for more than $6 million of urine-based drug tests ...

The Amsterdam-based firm's PCR-based Molecular Culture ID test is used to detect more than 200 bacterial species, yielding results within five hours.

NEW YORK – Becton Dickinson announced Wednesday that it has obtained 510(k) clearance from the US Food and Drug Administration for an integrated solution to assist in the interpretation of ...

The firm recently announced agreements with Labcorp and Quest Diagnostics to provide its devices for self-collection of vaginal swab specimens.

IBL will develop biomarker panels for use with Grifols' random-access, single-molecule counting platform, and the firms will collaborate on testing workflows.

Mark Golden is stepping down as CEO of the Association for Diagnostics & Laboratory Medicine, effective Aug. 17 when his contract expires, the association said. He joined the organization in 2020 as ...